Sign In
Free Newsletter
Johnson & Johnson buying Alios for $1.75B
Johnson & Johnson is buying the biopharmaceutical company Alios BioPharma Inc. for about $1.75 billion.
Jury awards $3.27M in second vaginal-mesh lawsuit
Johnson & Johnson was ordered by a jury to pay $3.27 million to a woman who said a defectively designed vaginal-mesh implant eroded inside her and she had to have surgery.
J&J to settle hip-replacement suits for $2.5B
WASHINGTON — Johnson & Johnson said late Tuesday that it will pay $2.5 billion to settle thousands of lawsuits brought by hip replacement patients who accuse the company of selling faulty implants that led to injuries and additional surgeries. The agreement presented in U.S. District Court in Toledo, Ohio, is one of the largest for […]
FDA OKs first-of-a-kind diabetes drug from J&J
WASHINGTON — The Food and Drug Administration says it has approved a first-of-a-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar. The agency cleared J&J’s Invokana tablets for adults with Type 2 diabetes, which affects about 26 million Americans. The drug is a once-a-day medicine designed to lower […]
$8.3M awarded in DePuy hip implant case
LOS ANGELES — A jury on Friday awarded $8.3 million to a former prison guard who accused Johnson & Johnson’s DePuy Orthopaedics subsidiary of knowingly marketing a faulty hip implant that was later recalled. Jurors found that the ASR XL implant was defectively designed and caused metal poisoning and other health problems suffered by Loren […]
Dancer drops DePuy suit, may join federal action
A former dancer has withdrawn her claim against Johnson & Johnson over faulty hip replacements on the same day the trial was to start.
J&J board picks CEO to replace retiring chairman
NEW BRUNSWICK, N.J. — Johnson & Johnson Chairman Bill Weldon will step down from that post in late December and the world’s biggest maker of health products has picked new CEO Alex Gorsky to replace him. The New Brunswick, N.J., company had named Gorsky, 52, as CEO earlier this year, replacing Weldon. J&J said Friday […]
J&J, Pfizer to drop intravenous Alzheimer’s drug
NEW YORK — Pfizer Inc. and Johnson & Johnson said Monday they are ending development of an intravenous formulation of a drug to treat Alzheimer’s disease after the treatment failed in two late-stage clinical trials. The companies said bapineuzumab intravenous did not work better than placebo in two late-stage trials in patients who had mild […]
Like ‘Kleenex’ to ’tissue’, Apple’s ‘iPad’ is the only tablet people know
NEW YORK — Apple is on the verge of doing what few others have: change the English language. When you have a boo-boo, you reach for a Band-Aid not a bandage. When you need to blow your nose, you ask for Kleenex not tissue. If you decide to look up something online, you Google instead […]
FDA panel backs birth control patch despite risks
ADELPHI — A panel of federal health advisers said Friday that a birth control patch from Johnson & Johnson probably carries a higher risk of blood clot risks than older drugs, but should remain available as an option for women who have trouble taking a daily pill. The Food and Drug Administration’s panel of reproductive […]
J&J to settle criminal charge over Risperdal marketing
WASHINGTON — Johnson & Johnson has tentatively agreed to settle a single misdemeanor criminal charge related to a multi-year government investigation into the marketing of its psychiatric drug Risperdal. The company said Monday in a regulatory filing that the agreement related to an allegation that the company promoted Risperdal for unapproved uses. The agreement, which […]
Johnson & Johnson settles bribery case with feds
WASHINGTON — Pharmaceutical giant Johnson & Johnson has agreed to pay $70 million to settle civil and criminal charges of bribing doctors in Europe and paying kickbacks to the Iraqi government to illegally obtain business. The Securities and Exchange Commission says the company settled the charges with the agency and the Justice Department without admitting […]
